Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Dainippon claims series with potential for urinary incontinence

July 29, 1998

Dainippon's new agents for urinary incontinence

July 28, 1998

Therapeutics for urinary incontinence in development at Dainippon

July 23, 1998

PNU-37883A, a tool for studying the role of K-ATP in renin release

July 16, 1998

NIH finds new selective ligands for studying P2X1 purinoceptors

July 15, 1998

New hormonal agents discovered by Ligand

July 10, 1998

European marketing application submitted for RenaGel

July 10, 1998

Ditropan XL shows favorable efficacy/side effect profile in phase III study

July 8, 1998

Blockade of angiotensin II receptor reduces radiation-induced renal and lung injury

July 7, 1998

P&U characterizes dual inhibitor of both 5alpha-reductase isozymes

July 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...